@NovartisOncMed
Follow us on Twitter for the latest global medical news
SABCS 2022
At SABCS this year, we will share new data from our robust portfolio and advanced therapeutic platforms in breast and women’s cancer, showcasing our bold science in research.
Bold Science: Transforming Lives, Striving for Cures
Reimagining Cancer and Blood Disorders
Novartis continues to pursue scientific breakthroughs with the ambition to transform lives and renew patients’ hopes for the future. Novartis products reach more than 800 million people globally and we are finding innovative ways to expand access to our medicines.
